Advertisement
Screener

LEXICON PHARMACEUTICALS, INC. (LXRX) Graph

LXRX Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $692.00K; Revenue including tax (m); Cost of revenue $39.00K; Research and development $17.44M.
  • 2026-03-31: Revenue $21.10M; Revenue including tax (m); Cost of revenue $108.00K; Research and development $12.76M.
  • 2025-12-31: Revenue $5.49M*; Revenue including tax (m); Cost of revenue $201.00K*; Research and development $11.31M*.
  • 2025-09-30: Revenue $14.18M; Revenue including tax (m); Cost of revenue $10.00K; Research and development $18.76M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

LXRX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.License$0.00Product$680.00KRevenue$692.00KCost of revenue$39.00KOperating income-$26.54MOther income, net$1.72MResearch & development$17.44MSelling, general& administrative$9.75MNet income-$31.78M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

LXRX revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segment$692.00KRevenue$692.00KCost of revenue$39.00KOperating income-$26.54MOther income, net$1.72MResearch & development$17.44MSelling, general& administrative$9.75MNet income-$31.78M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$692.00K(m)$39.00K$17.44M$9.75M(m)(m)-$31.77M
2026-03-31$21.10M(m)$108.00K$12.76M$9.23M(m)(m)-$1.04M
2025-12-31$5.49M*(m)$201.00K*$11.31M*$8.76M*(m)(m)-$15.53M*
2025-09-30$14.18M(m)$10.00K$18.76M$7.60M(m)(m)-$12.77M
2025-06-30$28.87M(m)$33.00K$15.75M$9.35M(m)(m)$3.25M
2025-03-31$1.26M(m)$30.00K$15.30M$11.61M(m)(m)-$25.30M
2024-09-30$1.75M(m)$71.00K$25.78M$39.59M(m)(m)-$64.81M
2024-06-30$1.65M(m)$166.00K$17.64M$39.19M(m)(m)-$53.43M
2024-03-31(m)(m)$31.00K$14.37M$32.06M(m)(m)-$48.40M
2023-09-30(m)(m)$7.00K$17.56M$32.23M(m)(m)-$50.52M
2023-06-30(m)(m)$8.00K$14.54M$30.01M(m)(m)-$44.90M
2023-03-31(m)(m)$0.00$12.03M$19.14M-$31.17M(m)-$31.93M
2022-12-31(m)(m)(m)(m)(m)$30.31M*(m)(m)
2022-09-30(m)(m)$0.00$10.56M$12.58M-$23.13M(m)-$23.39M
2022-06-30(m)(m)$0.00$13.36M(m)-$24.04M(m)-$24.59M
2022-03-31(m)(m)(m)$14.93M(m)$23.42M(m)-$23.48M
2021-09-30(m)(m)$0.00$15.68M(m)$22.98M(m)-$23.12M
2021-06-30(m)(m)$0.00$10.26M(m)$18.19M(m)-$18.07M
2021-03-31(m)(m)$0.00$12.61M(m)$20.87M(m)-$20.96M
2020-09-30(m)(m)$633.00K$40.15M(m)$52.78M(m)$82.60M
2020-06-30(m)(m)$728.00K$57.30M(m)$73.74M(m)-$69.07M
2020-03-31(m)(m)$568.00K$55.18M(m)$70.44M(m)-$66.61M
2019-12-31$8.73M(m)(m)(m)(m)(m)(m)-$51.14M
2019-09-30(m)(m)$577.00K$26.66M(m)$69.77M(m)$226.09M
2019-06-30(m)(m)$1.33M$12.64M(m)$28.23M(m)-$23.02M
2019-03-31(m)(m)$553.00K$12.02M(m)$26.68M(m)-$21.80M
2018-12-31$17.07M(m)(m)(m)(m)(m)(m)-$16.78M
2018-09-30$6.97M$446.00K$551.00K$13.76M(m)$29.89M(m)-$27.40M
2018-06-30$13.80M$6.36M$838.00K$26.48M(m)$44.07M(m)-$34.55M
2018-03-31$25.37M(m)$533.00K$47.70M$14.86M$63.09M(m)-$41.82M
2017-12-31$33.97M(m)(m)(m)(m)(m)(m)-$26.61M
2017-09-30$27.67M$21.11M$599.00K$39.14M$16.72M$56.46M(m)-$29.81M
2017-06-30$12.09M$8.10M$537.00K$26.93M$18.48M$45.95M(m)-$34.66M
2017-03-31$17.96M(m)(m)$43.58M$14.87M$60.78M(m)-$31.92M
2016-12-31$23.04M(m)(m)(m)(m)(m)(m)-$32.42M
2016-09-30$27.72M(m)(m)$52.53M$12.26M$62.65M(m)-$36.02M
2016-06-30$20.09M(m)(m)$48.22M$8.42M$57.11M(m)-$38.11M
2016-03-31$12.49M(m)(m)$37.00M$8.40M$46.37M(m)-$34.88M
2015-12-31$127.28M(m)(m)(m)(m)(m)(m)(m)
2015-09-30$566.00K(m)(m)$23.11M(m)$34.24M(m)-$35.28M
2015-06-30$376.00K(m)(m)$20.77M(m)$27.06M(m)-$28.07M
2015-03-31$1.79M(m)(m)$20.86M(m)$28.32M(m)-$28.08M
2014-12-31$21.48M(m)(m)(m)(m)(m)(m)-$2.93M
2014-09-30$419.00K(m)(m)$24.11M(m)$40.76M(m)-$40.50M
2014-06-30$676.00K(m)(m)$21.19M(m)$26.79M(m)-$26.03M
2014-03-31$277.00K(m)(m)$23.95M(m)$30.75M(m)-$30.84M
2013-12-31$1.41M(m)(m)(m)(m)(m)(m)-$17.41M
2013-09-30$238.00K(m)(m)$25.40M(m)$31.45M(m)-$31.66M
2013-06-30$214.00K(m)(m)$23.69M(m)$28.84M(m)-$29.08M
2013-03-31$360.00K(m)(m)$20.33M(m)$25.91M(m)-$25.97M
2012-12-31$218.00K(m)(m)(m)(m)(m)(m)-$24.87M
2012-09-30$372.00K(m)(m)$19.19M(m)$29.43M(m)-$29.54M
2012-06-30$199.00K(m)(m)$19.36M(m)$25.68M(m)-$25.93M
2012-03-31$300.00K(m)(m)$23.04M(m)$29.68M(m)-$29.87M
2011-12-31$343.00K(m)(m)(m)(m)(m)(m)-$33.84M
2011-09-30$355.00K(m)(m)$19.66M(m)$26.05M$0.00-$26.10M
2011-06-30$555.00K(m)(m)$20.14M(m)$26.48M(m)-$26.64M
2011-03-31$596.00K(m)(m)$23.92M(m)$29.73M(m)-$29.63M
2010-09-30$781.00K(m)(m)$18.94M(m)$25.03M-$26.00K-$27.51M
2010-06-30$1.23M(m)(m)$20.24M(m)$25.31M(m)-$25.19M

Revenue and expense 6 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2026-06-30$21.79M(m)$147.00K$30.20M$18.98M(m)-$32.82M
2025-06-30$30.13M(m)$63.00K$31.05M$20.96M(m)-$22.04M
2024-06-30$2.78M(m)$197.00K$32.02M$71.25M(m)-$101.83M
2023-06-30(m)(m)$8.00K$26.57M$49.15M(m)-$76.84M
2022-06-30(m)(m)$0.00$28.28M(m)$47.46M-$48.06M
2021-06-30(m)(m)$0.00$22.87M(m)$39.06M-$39.02M
2020-06-30(m)(m)$1.30M$112.48M(m)$144.18M-$135.68M
2019-06-30(m)(m)$1.88M$24.66M(m)$54.91M-$44.81M
2018-06-30(m)$26.02M$1.37M$74.17M(m)$107.16M-$76.37M
2017-06-30$30.35M$25.67M$762.00K$70.52M$33.35M$106.72M-$69.95M
2016-06-30$32.58M(m)(m)$85.22M$16.81M$103.47M-$73.00M
2015-06-30$2.17M(m)(m)$41.63M(m)$55.38M-$56.15M
2014-06-30$953.00K(m)(m)$45.14M(m)$57.54M-$56.86M
2013-06-30$574.00K(m)(m)$44.02M(m)$54.75M-$55.05M
2012-06-30$499.00K(m)(m)$42.39M(m)$55.36M-$55.80M
2011-06-30$1.15M(m)(m)$44.07M(m)$56.21M-$56.27M
2010-06-30$2.87M(m)(m)$41.33M(m)$51.91M-$51.26M

Revenue and expense 9 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$44.31M(m)$73.00K$49.81M$28.56M(m)(m)-$34.81M
2024-09-30$4.53M(m)$268.00K$57.80M$110.84M(m)(m)-$166.64M
2023-09-30(m)(m)$15.00K$44.13M$81.38M(m)(m)-$127.36M
2022-09-30(m)(m)$0.00$38.84M$31.75M$70.59M(m)-$71.45M
2021-09-30(m)(m)$0.00$38.55M(m)$62.04M(m)-$62.15M
2020-09-30(m)(m)$1.93M$152.63M(m)$196.96M(m)-$53.08M
2019-09-30(m)(m)$2.46M$51.32M(m)$124.68M(m)$181.27M
2018-09-30(m)$26.47M$1.92M$87.94M(m)$137.05M(m)-$103.77M
2017-09-30$57.29M$46.78M$1.36M$109.65M$50.07M$163.18M(m)-$100.67M
2016-09-30$60.30M(m)(m)$137.75M$29.08M$166.13M(m)-$109.01M
2015-09-30$2.73M(m)(m)$64.75M(m)$89.63M(m)-$91.43M
2014-09-30$1.37M(m)(m)$69.25M(m)$98.29M(m)-$97.36M
2013-09-30$812.00K(m)(m)$69.42M(m)$86.21M(m)-$86.71M
2012-09-30$871.00K(m)(m)$61.58M(m)$84.79M(m)-$85.34M
2011-09-30$1.51M(m)(m)$63.72M(m)$82.26M$0.00-$82.37M
2010-09-30$3.65M(m)(m)$60.27M(m)$76.95M-$26.00K-$78.78M

Revenue and expense 12 month

Period endRevenueRevenue including taxCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$49.80M(m)$274.00K$61.12M$37.32M(m)(m)-$50.34M
2024-12-31$31.08M(m)$616.00K$84.48M$143.10M(m)$0.00-$200.40M
2023-12-31$1.20M(m)$85.00K$58.89M$113.98M(m)$0.00-$177.12M
2022-12-31(m)$0.00$0.00$52.82M$48.08M$100.90M$0.00-$101.94M
2021-12-31(m)$0.00$0.00$55.05M$32.34M$87.39M$0.00-$87.76M
2020-12-31(m)$33.00K$1.93M$153.62M(m)$204.38M(m)-$58.57M
2019-12-31(m)$289.23M$3.23M$91.92M(m)$180.63M(m)$130.13M
2018-12-31(m)$36.27M$2.49M$100.24M(m)$166.49M(m)-$120.55M
2017-12-31(m)$75.62M$1.90M$152.22M(m)$222.31M(m)-$122.99M
2016-12-31(m)$79.10M$0.00$163.97M(m)$206.43M$0.00-$131.44M
2015-12-31$130.01M(m)(m)$95.19M(m)$128.55M$0.00-$4.68M
2014-12-31$22.85M(m)(m)$89.28M(m)$123.22M-$70.00K-$100.29M
2013-12-31$2.22M(m)(m)$89.68M(m)$104.59M$0.00-$104.13M
2012-12-31$1.09M(m)(m)$82.57M(m)$109.50M$0.00-$110.21M
2011-12-31$1.85M(m)(m)$91.83M(m)$115.94M$0.00-$116.22M
2010-12-31$4.91M(m)(m)$78.52M(m)$100.63M-$26.00K-$101.78M
2009-12-31$10.70M(m)(m)$81.24M(m)$100.66M-$102.00K-$82.78M

Similar stocks

Stock NameCountryMarket CapPE Ratio
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78